Rite Aid Chooses Opko Health Unit for Drive-Up Coronavirus Testing Services
Opko Health's (NASDAQ: OPK) BioReference Laboratories is rapidly becoming a favored provider of onsite testing for COVID-19, the disease caused by the SARS-CoV-2 coronavirus.
Pharmacy giant Rite Aid (NYSE: RAD) announced Monday that BioReference will provide the testing services in the drive-thru COVID-19 testing sites it's beginning to deploy in the parking lots of some of its stores.
Image source: Getty Images.
Source Fool.com
